MPTP and parkinsonism.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000328:Adult; D001696:Biomechanical Phenomena; D006801:Humans; D009420:Nervous System / Q000187:drug effects; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D011725:Pyridines / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D019966:Substance-Related Disorders
D011725:Pyridines; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine